From Riverton, Utah, USA:
My 18 year old daughter was recently diagnosed with type 1 diabetes. She is now on insulin. I read that current research is now showing the possible importance of C-peptide in preventing long term damage to other organs in the body. Is this the case? Is it possible right now to get C-peptide that can be combined with my daughter's insulin?
Studies in Western Europe and Scandinavia in recent years have indeed shown that C-peptide can have a beneficial action on small blood vessels in the kidney, peripheral nerves and elsewhere probably by stimulating the enzyme sodium-potassium ATP transferase. So far as I know though, there has been no production for clinical use anywhere, and certainly it has not been endorsed by the FDA in the U.S.
My guess is that no pharmaceutical company here will make the necessary huge investment to get approval until there is a great deal more convincing evidence of benefit.
|Return to the Top of This Page|
Last Updated: (none)
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.